SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ)

CUSIP: 871639308

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM NEW
Total 13F shares
24,663,384
Share change
-11,000
Total reported value
$138,838,603
Put/Call ratio
28%
Price per share
$5.63
Number of holders
71
Value change
-$66,000
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 871639308?
CUSIP 871639308 identifies SGYPQ - SYNERGY PHARMACEUTICALS DEL - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q4 2013

As of 31 Dec 2013, SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,663,384 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Fund Advisors, FMR LLC, BAKER BROS. ADVISORS LP, State Street Corp, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., WALL STREET ASSOCIATES, MORGAN STANLEY, and UBS GLOBAL ASSET MANAGEMENT AMERICAS INC. This page lists 71 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.